Search research articles
Contact Us
Filters
Showing results (241-250 of 273) with videos related to
Page
of 28
Sort By:
BMJ (Clinical Research Ed.)
|
August 1, 2020
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Ac Siemieniuk, Jessica J Bartoszko, Dena Zeraatkar, et al.
Annals of Internal Medicine
|
May 11, 2026
Integrating Planetary Health in Health Guidelines (GRADE Guidance 46)
Thomas Piggott, Pakeezah Saadat, Alina Herrmann, et al.
Elife
|
October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Bronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
ERJ Open Research
|
February 16, 2022
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
Luis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
Annals of Internal Medicine
|
December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis
, Claire L Vale, Peter J Godolphin, et al.
BMJ Open
|
August 3, 2025
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings
Banafshe Hosseini, Amanda Condon, Bruno R da Costa, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
Karim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 273) with videos related to
Sort By:
Page
of 28
BMJ (Clinical Research Ed.)
|
August 1, 2020
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Ac Siemieniuk, Jessica J Bartoszko, Dena Zeraatkar, et al.
Annals of Internal Medicine
|
May 11, 2026
Integrating Planetary Health in Health Guidelines (GRADE Guidance 46)
Thomas Piggott, Pakeezah Saadat, Alina Herrmann, et al.
Elife
|
October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Bronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
ERJ Open Research
|
February 16, 2022
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
Luis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
Annals of Internal Medicine
|
December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis
, Claire L Vale, Peter J Godolphin, et al.
BMJ Open
|
August 3, 2025
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings
Banafshe Hosseini, Amanda Condon, Bruno R da Costa, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
Karim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
Page
of 28